Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-025570
Filing Date
2025-08-08
Accepted
2025-08-08 09:18:30
Documents
63
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q crvo20250630_10q.htm   iXBRL 10-Q 996818
2 EXHIBIT 10.4 ex_850102.htm EX-10.4 42717
3 EXHIBIT 10.5 ex_850097.htm EX-10.5 162987
4 EXHIBIT 31.1 ex_850098.htm EX-31.1 8871
5 EXHIBIT 31.2 ex_850099.htm EX-31.2 8898
6 EXHIBIT 32.1 ex_850100.htm EX-32.1 5072
7 EXHIBIT 32.2 ex_850101.htm EX-32.2 4954
13 cervologo.jpg GRAPHIC 25228
14 logo2.jpg GRAPHIC 8131
  Complete submission text file 0001437749-25-025570.txt   5113134

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA crvo-20250630.xsd EX-101.SCH 44568
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20250630_def.xml EX-101.DEF 297271
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20250630_lab.xml EX-101.LAB 262628
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20250630_pre.xml EX-101.PRE 320594
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crvo-20250630_cal.xml EX-101.CAL 26173
66 EXTRACTED XBRL INSTANCE DOCUMENT crvo20250630_10q_htm.xml XML 710459
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 251196450
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)